Company Profile: Avita Medical Limited (ASX: AVH) is a group addressing both medical and aesthetic indications. Primarily, Avita Medical Ltd is a medical technology company which develops, manufactures and distributes innovative products for the regenerative medicine and respiratory markets. The company has a clinical pipeline of products with great value. Further, its platform is capable of delivering more regenerative medicine products in the future.
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s
Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.
Click here for your FREE Report